IL1B and breast carcinoma: In addition, in both melanoma and E0771 breast cancer models, IL1β has been shown to increase the anti-tumour potential of T helper (Th1) cells, and genetic knockout of IL1β in mice reduces cytotoxic CD8+ T cells in soft tissue tumours [13,18].